Coleman Obasaju Selected Research

Bevacizumab (Avastin)

10/2012	Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancer.
8/2011	A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.
7/2009	Treatment rationale and study design for the pointbreak study: a randomized, open-label phase III study of pemetrexed/carboplatin/bevacizumab followed by maintenance pemetrexed/bevacizumab versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with stage IIIB or IV nonsquamous non-small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Coleman Obasaju Research Topics

Disease

14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 09/2005
7	Neoplasms (Cancer) 01/2019 - 10/2008
3	Lung Neoplasms (Lung Cancer) 01/2018 - 11/2005
3	Disease Progression 01/2017 - 07/2009
2	Breast Neoplasms (Breast Cancer) 10/2012 - 08/2011
1	Exanthema (Rash) 01/2017
1	Neutropenia 06/2016
1	Thrombocytopenia (Thrombopenia) 06/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2008
1	Malignant Mesothelioma 03/2008
1	Dyspnea (Shortness of Breath) 09/2005
1	Fatigue 09/2005
1	Lymphoma (Lymphomas) 08/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2005
1	Body Weight (Weight, Body) 09/2002

Drug/Important Bio-Agent (IBA)

11	Pemetrexed (MTA)FDA Link 01/2016 - 09/2005
9	Gemcitabine FDA Link 01/2017 - 08/2005
5	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 07/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 10/2013
3	necitumumabIBA 01/2018 - 06/2016
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 07/2009
3	PlatinumIBA 01/2016 - 03/2010
3	Bevacizumab (Avastin)FDA Link 10/2012 - 07/2009
2	Monoclonal AntibodiesIBA 01/2017 - 08/2005
1	antineoplaston A10 (A 10)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	taxaneIBA 10/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2010
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	VitaminsIBA 11/2008
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2008
1	Messenger RNA (mRNA)IBA 10/2008
1	Thymidylate SynthaseIBA 10/2008
1	Transaminases (Aminotransferases)IBA 09/2005
1	CreatinineIBA 09/2002

Therapy/Procedure

11	Therapeutics 01/2018 - 08/2005
8	Drug Therapy (Chemotherapy) 01/2017 - 08/2005
2	Radiotherapy 03/2015 - 10/2013
2	Adjuvant Chemotherapy 11/2013 - 11/2005
1	Treatment Delay 11/2005
1	Aftercare (After-Treatment) 08/2005